团队成员
James Xin
Partner
32 years of senior executive experience in China pharmaceutical industry. Leadership positions in China medical & regulatory affairs at Novartis, Sanofi, J&J, and Livson. At Elite, Ten years of financial advisory in pharmaceutical and medtech industry, 15 years of experience in management consulting to the China pharmaceutical industry.
Ray Shen
Partner
Over 27 years of experience in marketing management, strategy consulting and market research in China pharmaceutical industry. Led and participated in nearly one hundred projects, focusing on China growth strategy, opportunity assessment and commercial due diligence. Has worked as a consultant with top multinational companies, including Novartis, Roche and Bayer, as well as top PE investors, including Blackstone, Morgan Stanley and the Carlyle Group.
Micah Zimmerman
Partner
17 years of experience in China as a healthcare executive and pharmaceutical industry consultant. President Asia Pacific for First Databank (Hearst Corp); Corporate Executive for UnitedHealthcare International (Hong Kong). 15 years of experience in pharmaceutical and medical device marketing research and management consulting (The Wilkerson Group, New York; Strategic Marketing Asia Beijing). Nine years biomedical M&A financial advisory (Elite Capital Advisors).
Alex Li
Partner
Veteran of 30 years in Healthcare industry, Dr. Li practiced clinical medicine in the U.S. for ten years. Then he spent next ten years as an entrepreneur to develop biopharmaceutics and commercialized a subunit flu vaccine and a recombinant protein drug in China. He then moved to private equity investment for the last ten years with enriched experience in healthcare industry. His expertise is in health service and biopharma with particular interest in mergers and acquisitions.
Ying Shao
Partner
Served as Head of the Chemical Drug Review Department of the Center for Drug Evaluation (CDE) of the State Food and Drug Administration, and was a long-time contributor to the research and formulation of national drug registration and regulatory policies, as well as the technical evaluation and management of drug marketing licenses. Previous industry experiences include Vice President and Director of R&D center for Fosun, and former CEO of NMS Group in Italy. PhD in Pharmaceutical Chemistry from China Pharmaceutical University.
Matthew Estes
Partner
29 years of senior executive experience in China. As Founder/CEO of BabyCare Ltd. in Beijing (sold to USANA, NYSE:USNA), grew China business from zero to $350M revenue and 250,000 distributors. Founder of Yaolan.com, a leading parenting Internet media company with 12 million active registered users. Prior was Managing Director Wella China (haircare); Sales & Marketing Director SmithKline China (GSK); Vice Chair of AmCham China (American Chamber of Commerce); YPO (Young Presidents Organization) Beijing Chapter Chair.
Fenghui (Daniel) Guo
Partner
Over 20 years of experiences in product valuation, financing, and acquisition/ merger with focus on medical devices and pharmaceutical industries. Master’s degree from Peking Union Medical College; MBA and a MS in biomedical from Purdue university. Previously worked with Capital One, and Wells Fargo for over 10 years. Founded First Horizon in 2015 and has successfully introduced over 10 medical products to China during the past 5 years.
Yang Wang
Vice President
Ten years of experience in China pharmaceutical industry, led and participated in various projects focusing on China opportunity assessment, product valuation, commercial due diligence, and China entry strategy. Expertise in helping overseas pharmaceutical and medtech companies enter China. Master’s degree in Administration (Healthcare) from the University of South Dakota and Bachelor’s degree in Communication from University of California, San Diego.
Ding Lee
Project Manager
Dr. Ding has over 30 years of experience in China healthcare industry. Dr. Ding started his career in the marketing department of Xi’An Janssen, and later went on to serve in senior executive roles in marketing for Zhejiang Hisun, Shandong Geneleuk, Jiangsu Nhwa, Abbott, and henyang 3Sbio.
Margaret Guo
Regulatory Supervisor
Ms. Guo has 9 years of experience in China healthcare industry. Prior to joining Elite, Ms. Guo served as Regulatory Affairs Specialist for Jyton Group, where she successfully completed more than 30 registrations for products from the U.S., Israel and South Korea, including bone cement, soft contact lens, hollow fiber dialyzer, intraocular lens, guide wire, implant and drill.
;